SCHEMBL28673736

SCHEMBL28673736

O=C(O)c1ccc(-n2nnnc2SCC(O)c2ccc(C3CC3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.53
▸ MEN1 O00255 5/20 0.48
▸ KMT2A Q03164 5/20 0.48
▸ ALDH1A1 P00352 5/20 0.48
▸ MAPK1 P28482 2/20 0.48
▸ PPARG P37231 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.46
▸ ATM Q13315 1/20 0.43
▸ POLB P06746 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ TSHR P16473 2/20 0.41
▸ DHODH Q02127 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28670742 0.85 HPGD (0.50) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL28669731 0.85 MAPK1 (0.60) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL28655968 0.85 KMT2A (0.58) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL28664794 0.84 HPGD (0.49) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL21952042 0.83 MAPT (0.59) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL28660621 0.82 SMN1; SMN2 (0.58) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL28676731 0.82 HPGD (0.51) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL24029051 0.82 MEN1 (0.53) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL24019625 0.82 MEN1 (0.53) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL24029052 0.82 MEN1 (0.53) HPGDMEN1KMT2AALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115768422-A Ubiquitin ligase inhibitors for the treatment of cancer 诺沃亚桑托斯教授基金会 2023-03-07 — — CN disclosed
CN-113677340-A Compounds that selectively and efficiently inhibit Hakai-mediated ubiquitination as anti-cancer agents 诺沃亚桑托斯教授基金会 2021-11-19 — — CN disclosed
Send feedback